Literature DB >> 6875615

Infantile centronuclear myopathy. Evidence suggesting incomplete innervation.

G B Elder, D Dean, A J McComas, B Paes, D DeSa.   

Abstract

A male case of centronuclear myopathy is reported, with severe weakness at birth and death at 7 weeks. In all the muscles studied the fibres, despite their immature appearances, showed normal histochemical differentiation into type I and type II moieties. In contrast to the extrafusal fibres, the intrafusal fibres seemed to be normal in their development. Although the small centrally-nucleated muscle fibres were equipped with motor end-plates, the EMG revealed profuse fibrillation activity. The conflicting findings are postulated to arise from the presence of inexcitable neuromuscular junctions which nevertheless permitted a neurotrophic influence to be exerted on the muscle fibres.

Entities:  

Mesh:

Year:  1983        PMID: 6875615     DOI: 10.1016/0022-510x(83)90128-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  X linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci.

Authors:  N S Thomas; H Williams; G Cole; K Roberts; A Clarke; S Liechti-Gallati; S Braga; A Gerber; C Meier; H Moser
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

2.  Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia.

Authors:  Teerin Liewluck; Xin-Ming Shen; Margherita Milone; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-04-08       Impact factor: 4.296

Review 3.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

4.  Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.

Authors:  Elizabeth M Gibbs; Nigel F Clarke; Kristy Rose; Emily C Oates; Richard Webster; Eva L Feldman; James J Dowling
Journal:  J Mol Med (Berl)       Date:  2013-01-22       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.